PMVP

NASD PMV Pharmaceuticals, Inc.
Nov 4, 2026 · 11:53 PM ET EOD Market Closed

$1.33 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.33, $0.12 below the day’s high of $1.44

YTD change
+6.00%
vs 20-day SMA
-0.97%
vs 200-day SMA
+1.66%

Price ranges

Previous day
$1.33 $1.42
open $1.37 close $1.38
+$0.01 (+0.73%)
Today
$1.31 $1.44
open $1.40 now $1.33
-$0.08 (-5.36%)
Past week
$1.21 $1.42
from $1.25 now $1.33
+$0.08 (+6.00%)
Past month
$1.10 $1.61
from $1.61 now $1.33
-$0.29 (-17.70%)
This year
$1.02 $1.91
from $1.25 now $1.33
+$0.08 (+6.00%)

Price & Performance

-0.07 (-5.36%) / 6M

$0.9908$1.28$1.56$1.85May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 97.9% away from all-time highs of $63.22
  • PMVP is up 6% since the beginning of the year
  • PMVP is down 1% over the past 12 months
  • PMVP is down 18% over the past 1 month
  • 2% of all PMVP investors are betting against PMVP

PMVP reads not so good: price sits above one of the two key moving averages, the 12-month move is -1.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.34
Earnings momentum -1.0% Quarterly EPS growth
Quarterly change -1.0%

Valuation

P/E ratio N/A
Enterprise value $-5540060.0
Beta 2.18

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$79.4M
Debt$217.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $126.4M

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.